Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001774807-25-000005
Filing Date
2025-10-16
Accepted
2025-10-16 18:49:13
Documents
1
Period of Report
2025-10-15

Document Format Files

Seq Description Document Type Size
1 form4-10162025_101009.html 4  
1 form4-10162025_101009.xml 4 5892
  Complete submission text file 0001774807-25-000005.txt   7399
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
TALPHERA, INC. (Issuer) CIK: 0001427925 (see all company filings)

EIN.: 412193603 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address
Todisco Joseph (Reporting) CIK: 0001774807 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35068 | Film No.: 251398666